A perspective on more effective GPCR-targeted drug discovery efforts

Area of Science:

• Pharmacology
• Molecular Biology
• Drug Discovery

Background:

• G-protein-coupled receptors (GPCRs) represent the largest receptor family in mammals and are validated drug targets.
• GPCR activation involves ligand binding, conformational changes, G-protein coupling, and downstream signaling.
• GPCR signaling can be modulated at multiple points, including ligand binding, G-protein coupling, and receptor trafficking.

Purpose of the Study:

• To review key considerations for developing screening campaigns for GPCRs.
• To guide the validation of hits identified from primary GPCR screening.
• To highlight the importance of selecting appropriate technologies for ligand identification.

Main Methods:

• Review of GPCR structure and function.
• Analysis of screening strategies for GPCRs.
• Discussion of hit validation methodologies.
• Consideration of key contact sites in GPCR-ligand interactions.

Main Results:

• Identified critical factors for designing effective GPCR screening campaigns.
• Outlined strategies for validating screening hits.
• Emphasized the need for tailored approaches based on GPCR characteristics.

Conclusions:

• The choice of screening assay should align with the therapeutic goal, e.g., inflammation.
• Prioritize screens that measure physiological endpoints like chemotaxis.
• Utilize relevant cell types and endogenous receptors for robust validation.